Trial Profile
Maintenance Trial by Orencia in Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2017
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms MATADOR
- 27 Sep 2016 Status changed from active, no longer recruiting to completed.
- 27 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 26 Mar 2013 New trial record